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Analytical methods for hazard and risk analysis are being considered for controlling contamination
in pharmaceutical cleanrooms. The most suitable method appears to be the HACCP system that has
been developed for the food industry, but this requires some reinterpretation for use in
pharmaceutical manufacturing. This paper suggests a possible system.
To control contamination effectively, it is necessary to have a good appreciation of the routes and
sources of contamination, and the means of controlling them. An overview of these is given.
Introduction
Cleanrooms must be operated so that the contamination of the
manufactured product is controlled. Standards of particle and
microbial contamination, such as found in the European
Union guide to good manufacturing practice1 are set, and
controlled, so that they are not exceeded. Unfortunately, such
standards do not take account of different degrees of risk, the
varying routes and sources of contamination in different
processes, and whether the product supports the growth of
micro-organisms. To ensure that the correct control measures
are taken, a scientifically based contamination control system
is needed to analyse the degree of risk posed by the varying
hazards. This approach has been advocated by ISO 14698-12.
Hazard and risk analytical systems
A contamination control system should assess the degree of
risk of potential hazards found in a cleanroom. A number of
systems exist for assessing risk during manufacturing, and
ISO 14698-1 suggests Fault Tree Analysis (FTA)3, Failure
Mode and Effect Analysis (FMEA)4 and Hazard Analysis and
Critical Control Point (HACCP)5, 6, 7. The first two systems
appear to have been written mainly for electrical and
mechanical systems, but can be applied to all types of risks.
Those who are expert in dealing with such systems will be
able to apply them to contamination risks. However, the
majority of cleanroom users will more easily understand the
Hazard Analysis and Critical Control Point (HACCP)
system, which is the basis of the system used in ISO 14698-1.
This system was devised for use in preventing contamination
in the food production industry. It has the following seven
principles 7:
1. Conduct a hazard analysis
2. Determine the critical control points (CCPs)
3. Establish critical limit(s)
4. Establish a system to monitor control of the CCPs
5. Establish the corrective action to be taken when
monitoring indicates that a particular CCP is not under
control
6. Establish procedures for verification to confirm that the
HACCP system is working effectively
7. Establish documentation concerning all procedures and
records appropriate to these principles and their
application
It is also suggested in some HACCP documents that
personnel associated with the HACCP system need to be
trained.
The HACCP system is explained in various documents5, 6, 7.
However, these documents and explanations apply to the food
industry. The HACCP system clearly needs reinterpretation if
it is to be used in pharmaceutical production. There has been a
considerable amount of discussion as to how this can be done,
and its application to the wider aspects of pharmaceutical
manufacturing has been reported8, 9. However, HACCP can
be applied just to the control of microbial and particle
contamination. Used in this way, it should add a scientific
rationale to existing quality assurance systems. In the
pharmaceutical industry, where the regulation process is often
based on what is achievable rather than a scientific
assessment what is required, this is a welcome addition.
A cleanroom contamination control system
As indicated in the previous paragraph, the HACCP system
requires some reinterpretation if it is to be used in the
manufacture of non-food items in cleanrooms. A
reinterpretation of the first three principles of HACCP is
particularly needed. To achieve this, a cleanroom
contamination control system (CCCS), based on HACCP, is
suggested. This contains the following steps:
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Personnel within the cleanroom are a major source of
contamination and normally the sole source of micro-
organisms. They can disperse contamination from the
skin, mouth and clothing. This contamination can be
transferred to the product through the air, or by contact
with their hands or clothing.
Machines are another source, as they can generate
contamination by the movement of their constituent parts
or may be a secondary source from contamination
deposited on them from personnel; ancillary equipment
used in the process should not be forgotten, although
many can be considered in the 'surfaces' category. Raw
materials, containers and packaging that are brought in, or
piped into the cleanroom, may be contaminated and
should be considered as sources.
2. Routes of transfer
As well as identifying the sources of contamination in a
cleanroom, the routes of transfer must be considered. The
two main routes are airborne and contact.
Contamination can be dispersed into the air from
sources and transferred to the product. If the particles are
small, like skin cells, they can float off to other parts of the
cleanroom. However, if they are large, like spittle or
cuttings, they will remain within a short distance from
where they were generated, and fall directly into, or onto,
the product; this is often called intimate airborne spread.
Contact routes of contamination occur when
contaminated machines, ancillary equipment, containers,
packaging, raw materials, gloves, clothes, etc. come
directly into contact with the product. Contact
contamination can occur in several ways; one example is
when personnel handle a surface and the contamination on
their gloves is transferred onto the product. Another is
when the product is filled into contaminated containers.
Using information of the type discussed in this and the
previous section, the sources and routes of transfer can be
ascertained and a risk diagram constructed for any
cleanroom.
3. Construction of a risk diagram
Construction of a ‘risk diagram’ is a good method of
understanding how contamination arises from sources, as
well as the routes by which it reaches the product. The risk
diagram is equivalent to the HACCP flow diagram. The
way in which a product is contaminated is often poorly
understood, but by constructing a risk diagram a greater
understanding will follow. The risk diagram should show
possible sources of contamination, their main routes of
transfer, and methods of controlling this transfer. It may
be necessary to construct several diagrams where (a) the
process is carried out in several rooms (b) one part of the
process is very complex or (c) where it is necessary to
control different contaminants, e.g. particles and micro-
organisms.
Figure 1 is an example of a risk diagram that is
produced for a single cleanroom and shows the main
sources of microbial and particle contamination. It
includes the main routes of transfer of contamination and
the means of controlling them. The transfer of
contamination around the room can be very complicated
1. Identify the sources of contamination in the
cleanroom. Construct a risk diagram, or diagrams, to
show these sources and their routes of contamination.
2. Assess the importance of the sources to determine
how great a hazard they are.
3. Identify methods that can be used to control these
hazards.
4. Determine valid sampling methods to monitor the
hazards, or their control methods, or both.
5. Establish a monitoring schedule with ‘alert’ and
‘action’ levels, and corrective measures to be taken,
where appropriate, when these levels are exceeded.
6. Verify that the contamination control system is
working effectively by reviewing the product
contamination rate, sampling results and control
methods and, where appropriate, modifying them.
7. Establish and maintain appropriate documentation.
8. Train the staff.
CCCS Step 1: Identification of sources and
routes of contamination 
The first step of the CCCS system is the identification of
the sources and routes of contamination, and can be
carried out as follows:
1. Sources of contamination
All sources of contamination should be identified for the
process being analysed. Examples of sources of
contamination in a typical cleanroom are as follows:
• areas adjacent to the cleanroom
• unfiltered air supply
• room air
• surfaces
• people
• machines
• ancillary equipment
• materials
• containers
• packaging
Areas adjacent to the cleanroom are likely to be more
contaminated than the production cleanroom; the material
airlock and clothing-change areas will be contaminated by
the activities going on in these areas and the
contamination in the outside corridors and service areas
may not be controlled. The air supplied to a room, if not
correctly filtered, is a source of contamination. Room air
is also a source as it contains contamination dispersed into
it from other sources, such as people and machines.
The floor, walls, ceiling and other surfaces in the
cleanroom are examples of surface sources, their
contamination being derived in a secondary way from
personnel touching them, or contamination depositing
from the air. These surfaces can also be primary sources of
contamination if poor quality constructional components
are used, which break up and disperse fibres, wood chips,
plaster, etc. Cleanroom clothing, gloves and masks are
other surfaces that are contaminated, either by the people
wearing them or from other cleanroom surfaces.
as, in theory, everything in the cleanroom can be
contaminated by everything else. However, in practice, it
should only be necessary to consider the major ones. It is
interesting to note the central role of air, which receives
and transports many of the sources in a cleanroom. This
agrees with the fact that airborne microbial contamination
has been shown to have a central role in contamination in
aseptic production10, 11, 12, 13. Because of its complexity,
the means of controlling the manufacturing process has
not been fully shown in Figure 1, and is shown separately
in Figure 2. which has been drawn to include
manufacturing materials.
CCCS Step 2: Assessment of the importance of
hazards
When all possible sources of contamination in the
cleanroom, and their routes of transmission, have been
identified, the next task is to carry out a risk assessment.
This is also called a hazard or risk
analysis and ascertains what sources of
contamination are important, i.e. their
relative importance, or degree of risk.
It may be difficult to determine which
contamination sources are the most
hazardous. This is especially so if the
cleanroom is new and not yet operational, as
few useful results will have been collected
of the concentration of contaminants in the
environment. However, lack of results
should not prevent a preliminary assessment
being made, as it will be necessary at a later
stage (Step 6) to return to these tentative
conclusions for a reappraisal and, if
necessary, make changes.
To determine the likely importance of
a hazard, the following method may
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assist. Firstly, a set of variables known as risk factors
should be determined. These are:
1. The amount of contamination on, or in, the source in
its uncontrolled state and available for transfer (risk
factor A);
2. The ease by which the contamination is dispersed or
transferred (risk factor B);
3. The proximity of the source to the critical point where
the product is exposed (risk factor C);
4. How well the contamination is controlled (risk factor
D).
Table 1 shows the risk factors and score values that can be
used to assess the overall risk rating, or hazard, of each
individual source. Each of these factors (A to D) should be
assessed and given a score of 0 to 2.
Using Equation 1, the four scores should be multiplied
together to obtain a risk rating. This will have a value of
between 0 and 16.
Risk rating = A × B × C × D Equation 1
A risk rating can therefore be obtained for each
contamination source and this rating can be used to
determine the importance of each source and whether it is
Figure 1. Sources and routes of particle and microbial contamination in a
cleanroom along with preventative measures. The boxes give sources
and the connecting lines give the means of control. 
* Cleaning includes disinfection and sterilisation where appropriate.
Figure 2. Sources and routes of control often associated with process
machinery. (1) Contamination of the raw materials, containers and
packaging can be controlled by production in suitably clean
conditions. (2) Cleaning methods include disinfection or sterilisation.
Table 1. Risk factors for assessing hazards
Amount of Ease of dispersion, Proximity from Effectiveness of 
contamination on, or transfer (B) critical area (C) control method (D)
or in, a source (A)
0 = nil 0 = nil 0 = remote 0 = barrier control
0.5 = very low 0.5 = very low 0.5 = outside 0.5 = very good 
corridor, air lock control
1 = low 1 = low 1 = periphery of 1 = good control
cleanroom
1.5 = medium 1.5 = medium 1.5 = general area 1.5 = some control
of cleanroom
2 = high 2 = high 2 = critical area* 2 = no control
*A critical area is where the product is open to contamination, or where any materials
that come into intimate contact with the product are placed.
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a hazard to the product. If required, the risk rating can
assigned a ‘low’, ‘medium’ or ‘high’ category. For
example, a risk rating of less than 4 can be considered as
‘low’, between 4 and 12 as ‘medium’ and higher than 12
as ‘high’. Experience with the system will help develop a
useable system. This risk rating can then be used to help
determine how much effort should be put into controlling
and monitoring each source. However, it should be
appreciated that this method should only be used to assist
in assessing the risks. The quality of the information
available as input and the inexact nature of the
mathematical model means that it cannot give exact
predictions.
Two examples of a risk assessment will demonstrate
the general method.
Example 1 
A risk assessment is required to answer the question ‘how
great a hazard are cleanroom walls?’. Firstly, the ‘amount
of contamination’ factor (A) should be assessed. As the
amount of contamination on the walls is ‘low’, a score of 1
could be given. The ‘ease of dispersion or transfer’ (B) is
likely to be ‘very low’ and given a score of 0.5. As the
wall is at the periphery of the room, a value of 1 is given to
the ‘proximity’ score (C). A score of 1 might be an
appropriate score for the ‘effectiveness of control method’
(D) if the wall was cleaned frequently, 1.5 if it was
cleaned irregularly and 2 if it was never cleaned. Thus, the
overall hazard assessment score of between 0.5 and 1
would be obtained. This demonstrates that walls are not an
important hazard.
Example 2
The hands of a person handling a product are considered.
Maximum scores of 2 could be given for both the ‘amount
of contamination’ in the uncontrolled state' (A) as well as
‘the ease of dispersion, or transfer’ (B), as ungloved hands
have very large amounts of particles, bacteria and salts,
and these are easily transferred when personnel handle the
product. A maximum score of 2 could also be assigned to
the ‘proximity from the critical area’ if the operator
handles the product, although this should be changed to 1
if the product is infrequently handled. The overall hazard
assessment score is now dependent on how the hand
contamination is controlled. If no gloves were worn, a
hazard score close to the maximum of 16 can be calculated
from Equation 1. If gloves were worn, then, depending on
how likely they were to be punctured, an overall hazard
score of about 8 would be obtained. The use of double
gloves, or gauntlets in an isolator, would give either very
good control, or barrier protection; this would reduce the
overall hazard score to close to 0. It can be seen from this
example that hands can be a high potential hazard and
their control is important.
Ljungqvist and Reinmüller14,15 describe a method that can
be used to determine the risk caused by imperfect air
protection of production machinery. They suggest that the
airflow round the machinery should firstly be investigated
by smoke visualisation techniques. The area outside the
machinery should then be seeded with a known
concentration of particles ≥ 0.5µm, and the number of
particles that penetrate into the critical areas where the
product is open to contamination should be counted. The
ratio of particles found at the critical area, to those seeded
outside is then calculated and this ratio used as an
indication of the risk of product contamination. The
authors consider that if the ratio is 10-4 or better, then there
is no chance of microbial contamination during
production. This is a useful approach, but does not take
into consideration the following variables: (a) the
concentration of micro-organisms in the air outside the
machinery, (b) the area of the product that is open to
contamination, e.g. the neck of a container, and (c) the
time that the product is exposed to contamination. Their
method can be improved if account is taken of these
variables.
If a settle plate is used to determine the deposition rate
of the micro-organisms at the point of production, then the
contamination of a product can be ascertained11,12,13. It is
also possible to use sampling results from an active
sampler, but deposition velocity of the microbe-
containing particles has to be determined; the settle plate
method is best. The following simple equation can then be
used to determine the likely contamination rate of
products:
This equation assumes that the settle plate count has been
taken at the process filling point. However, if the settle
plate count is taken in the area outside the machinery, and
this count multiplied with the risk ratio then the count at
the critical point can be estimated. The likely
contamination rate of the product can then be ascertained.
This is illustrated by the following example:
A cleanroom room where a machine and its air
protection system is situated gives a microbial count of 30
from a 14-cm Petri dish (154 cm2 area) exposed in the
room air for four hours. The number of micro-organisms
likely to deposit into the container of a neck area of 1 cm2,
when they are open during filling, for an average of 10
minutes, and when the risk factor ratio has found to be
10–3 is therefore:
10–3 × 30 × 1 × 10 = 0.000008 (i.e. 8 containers in 106 )
154 60 x 4
Comparisons can be made between different risk ratios,
and hence the hazard assessed for a specific process.
CCCS Step 3: Identification of methods to
control hazards
When all the contamination hazards in the cleanroom have
been identified, and their degree of risk assessed, it is then
necessary to review the methods available to control them.
This is approximately equivalent to the HACCP
requirement that critical control points should be
identified. The importance of obtaining an effective
control method should be related to the risk assessment
described in Step 2; the greater the risk, the more effective
the control method should be. It is also necessary to show
Contamination
=
Settle plate × area of product × time product exposed
rate count area of petri dish time settle plates exposed
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that the control method is effective. If it is not, then either
a more effective control method should be adopted, or the
control method applied to a different point or place.
Figures 1 and 2 show methods that can be used to control
the routes of spread of contamination. These are:
1. HEPA air filters can be used to prevent any
contaminants entering with the supply air. However,
unfiltered air can pass through holes in damaged
filters, or by-pass the filter owing to poor filter
housing construction.
2. Airborne contamination from areas outside the
cleanroom, e.g. outside corridors and service areas,
can be prevented from entering the cleanroom by
ensuring that the air moves from the cleanroom
outwards, i.e. from clean to less clean. Air locks
and/or a cascade flow of air through the doorways
will ensure this. The use of adhesive cleanroom mats
and flooring, as well as the removal, or covering, of
dirty outdoor shoes prevents surface contamination
being transferred into the cleanroom.
3. Although cleanroom air is a transfer route, it is also a
source. Such airborne sources of contamination can
be reduced by the use of a conventional turbulent
ventilation system to dilute it, a unidirectional
ventilation system to sweep it away, or an isolator to
provide a barrier.
4. The possibility of transfer of contamination from
surfaces such as floors, walls, ceiling, trolleys, etc. is
minimised by cleaning and disinfecting, and any
contamination that becomes airborne is controlled by
ventilation.
5. People disperse contamination from their mouth, hair,
clothing and skin. Cleanroom garments and gloves
will minimise this dispersion, and contamination that
cannot be controlled (as well as that produced by their
clothing) can be minimised by the ventilation system.
6. Contamination from machines and ancillary
equipment can be minimised by design, or by the use
of local ventilation to control it, e.g. unidirectional
flow or exhaust air systems. Cleaning and disinfection
can control surface dirt and micro-organisms.
7. Raw materials, containers and packaging, should be
uncontaminated. They should be made from suitable
materials and manufactured in an environment that
ensures that they have minimal concentrations of
contamination on or within them. They should be
correctly wrapped to ensure that they are not
contaminated during delivery to the process, and that
when the packaging is removed, contamination does
not occur. Materials that are not sufficiently clean
will require to be cleaned and either disinfected or
sterilised; fluids can be filtered.
CCCS Step 4: Sampling methods to monitor
hazards and control methods
It will now be necessary to set limits and monitoring
methods to ensure that contamination of the
manufacturing process is kept under control. This step is
equivalent to the HACCP fourth principle. If air is taken
as an example, then there are well-established methods of
measuring particles and micro-organisms, and standards
such as ISO 14644-116 and the EU guide to good
manufacturing practice1 should be used to set limits.
However, if personnel handling the product cause the
hazard, and the control measure is the wearing of gloves,
monitoring could be by inspecting for punctures and tears
in the gloves, or measurement of micro-organisms on the
surfaces. Some well-known cleanroom hazards, their
routes of transfer and control, and typical methods used to
monitor them are given in Table 2.
Step 4 of the HACCP system requires that ‘valid
sampling methods’ be used. The term ‘validate’ is defined
here as ‘ensuring that something is fit for the purpose, or
works well in the situation in which it is being used’. In
terms of monitoring, the following may be need to be
demonstrated to ensure that valid sample methods are
being used:
1. Collection efficiency of sampling instruments;
2. Calibration of sampling instruments;
3. Determination that the hazard is of sufficient
importance to need to be monitored, and if it is, the
frequency of monitoring;
4. Determination that the sampling method used is the
best available for directly measuring the hazard, or its
control method.
The last two requirements are not easy to determine, but, if
done scientifically in relation to the risk, they will ensure
that monitoring effort is not wasted.
CCCS Step 5: Establishing a monitoring
schedule with alert and action levels
In the third principle of HACCP there is a requirement to
establish critical limits. In most pharmaceutical
cleanrooms, the setting up of critical limits would be
equivalent to establishing ‘alert’ and 'action' limits for
environmental samples obtained during monitoring
procedures. These limits can only be established after
sampling methods have been decided upon, and some
initial results obtained. Hence it is best that the principles
of HACCP be re-arranged so that the limits are set now.
It is also necessary to consider the vulnerability of the
product to microbial growth. This requires an assessment
of both the likelihood of a micro-organism being
deposited onto the product, and its chance of multiplying.
The likelihood of a micro-organism being deposited into
or onto a product is dependent on the area of the product
that is open to contamination, and the time that it is open.
Hence, a 500-ml bottle with a wide neck that is open to
contamination for many minutes will have several
magnitudes more microbial contamination than a closed
ampoule that is opened and sealed in a few seconds. The
likely rate of airborne contamination can be determined by
the use of settle plate sampling and the use of the
equations discussed at the end of Step 211,12,13. The
likelihood of the pharmaceutical products supporting the
growth of micro-organisms should now be considered17. It
is possible to assess the vulnerability of the product to this
danger by submitting the product to growth tests with a
selected range of micro-organisms17. If the product is
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likely to support growth then, logically, the environmental
standards must be higher than products that have no
nutritional base, or contain antimicrobial agents. The
chances of the product being contaminated, as well as the
probability that the micro-organism will grow, are
important consideration that should influence the amount
of effort needed to control contamination; these properties
will help determine the alert and action limits to be set.
Some control methods may be continuously monitored,
as is the case with a cleanroom's air supply and over-
pressure. On the other hand, some inconsequential hazards,
such as the ceiling surface, may not be monitored. The
frequency of monitoring should be determined for each
hazard or control method. This should be set up with due
regard to the importance of the hazard: the higher the risk,
the more frequent the sampling should be.
It is also necessary to decide what corrective actions
should be taken when the monitoring result gives a higher
result than expected. A normal approach in
pharmaceutical manufacturing is to set ‘alert’ and ‘action’
conditions. The ‘alert’ level could be set to indicate that
the contamination concentrations are higher than might be
expected, but are still under control. Nothing will
normally be done if the ‘alert’ level is exceeded, as this is
a warning to be on the alert for future problems. However,
several ‘alerts’ in a relatively short time, or an unusual
result, might suggest that action is required. When the
‘action’ level is exceeded there must be an investigation.
An assessment should be made as to whether it is a
spurious result caused by natural variation, a mistake in
the collection of the results, or a real result. For those
results that are considered ‘real’, there should be an
investigation by an agreed method; this should assess
whether or not the result is acceptable and, if not, what
action is required to bring the situation under control.
Analysing the monitoring results and setting ‘alert’ and
‘action’ levels is quite a complicated subject if a statistical
approach is used. Knowledge of statistical techniques is
required and a discussion of this topic is outside the scope
of this paper. 
CCCS Step 6: Verification and reappraisal of the
system
A method must now be set in place to check that the
system has been correctly implemented. This is equivalent
to the sixth principle of HACCP.
Verification that the contamination control system is
working well can be carried out by measurement of the
particle or microbial levels in samples of the final product.
Simulation of the process, e.g. filling containers with
microbiological medium and ascertaining the microbial
contamination, is a method also used in pharmaceutical
manufacturing. As long as these give satisfactory results,
then the system could be considered to be working well.
However, depending on the vulnerability of the product to
microbial growth, it is also possible at this time to attempt to
reduce the contamination rate by introducing further controls.
Another additional approach is to verify the effectiveness of
the control measures by inspection and assessment of the
monitoring results. However, this is not as rigorous a
scientific method, as the contamination limits may have been
incorrectly set at the level that is above the concentration that
has any effect on the quality of the product.
We can now reassess the following:
1. The relative importance of the hazards
2. The necessity and the methods for controlling the
hazards
Table 2. Examples of sources, routes of transfer and control and monitoring methods used in cleanrooms.
Hazard Route Control method Monitoring methods
Supply air airborne air filters filter and filter housing integrity test
Areas adjacent to the cleanroom airborne overpressure; air movement room pressure differential
control
contact cleanroom mats mat inspection
Various airborne dispersions airborne ventilation air supply rate or velocity; counts of airborne 
particles; counts of airborne micro-
organisms; control of airflow
Floors, walls and other surfaces contact cleaning (and, where surface contamination counts
required, disinfection)
Personnel airborne cleanroom garments surface counts; inspection for tears; 
clothing testing 
contact gloves inspection for punctures; surface
contamination counts 
Machines airborne ventilation air supply and extract rates; air-flow 
patterns and risk ratios
contact design of machine; -
cleaning or disinfection surface contamination counts
Raw materials mainly contact control of manufacturing of contamination counts within, or on, the 
raw materials materials.
cleaning if solid, or filtration filtration and sterilisation systems
if fluid; sterilisation
Containers and packaging mainly contact control of their composition and contamination counts on surface
manufacturing environment;
sterilisation sterilisation system
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3. The effectiveness of the control methods
4. The correctness of the monitoring schedule
5. Whether the ‘action’ and ‘alert’ levels should be
lowered or raised.
It should be noted that this verification step requires an
appraisal of both the requirements for controlling the hazard
and to whether the ‘alert’ and ‘action’ levels need to
lowered or raised. Many of the present-day quality
assurance methods are based on the principle that if the
standards can be improved, they should be. Little thought is
given to whether they need to be improved and, inevitably,
standards and financial costs are raised. A scientific
approach requires a justification of the raising of standards.
This may indicate that control measures should be reduced.
CCCS Step 7: Documentation
An effective contamination control system will document
(1) the methods described in the preceding steps of this
chapter, (2) the monitoring procedures and (3) results
from the monitoring. These groups should be regularly
updated to incorporate changes.
Regular reports should be issued of an analysis of the
monitoring results and any deviations from the expected
results. When ‘action’ levels are exceeded these should be
reported. The actions taken to correct the deviations, or the
explanations as to why no action was necessary, should
also be documented. ‘Alert’ levels can also be reported,
particularly those with a multiple or unusual occurrence.
CCCS Step 8: Staff training
HACCP does not specify in its principles that staff have to
be trained. However, a reading of the various official
publications concerned with HACCP require training in
the principles of HACCP. This is clearly needed, but all
efforts to control contamination through a scientific
system will fail if the personnel working in the cleanroom
are not trained. They should be trained to understand how
the room works, and how to conduct themselves within
the cleanroom to minimise contamination. They should be
trained in these aspects of contamination, both when they
first arrive at the cleanroom, and at regular intervals
throughout their careers.
Conclusions and discussion
The purpose of writing this paper was two-fold. The first
was to give an overview of the sources and routes of
contamination in cleanrooms, and the means of
controlling these. A good knowledge of these is necessary
to control contamination in cleanrooms effectively. The
second reason, which is the more difficult, was to discuss
the application of the HACCP system to pharmaceutical
manufacturing. The HACCP system has been written for
the food industry and needs reinterpreting and
modification for use in non-food cleanroom situations. It
is hoped that this paper will assist in this.
The advantage of a HACCP-based system over what
exists today in the pharmaceutical manufacturing is that it
is scientifically based. Although existing methods of
pharmaceutical manufacturing are scientifically based,
there are aspects of a quality assurance based system that
can be improved. At present, there is often little in the way
of assessing the degree of risk of a hazard. This means that
the methods of controlling a hazard, the alert and action
limits set, and the frequency of monitoring may not bear a
close relationship to the degree of risk of contamination.
Clearly, this is a problem if a hazard has been
underestimated, but the contrary is also true. It is the
author’s opinion that, in some parts of pharmaceutical
manufacturing, both the control measures and the
frequency of monitoring are too great for the actual degree
of risk. Hospital patients must not get contaminated
medicines. However, there is a point at which
contamination control will fail to give improvements in
the quality of the product and add to the cost of providing
medicines. A contamination control system, such as
described above, will give a scientific dimension to
ensuring that there is a correct balance between too little
and too much control.
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